accountthe added indication. Data released yesterday certainly seems to support an approval. The vaccine looks good compared with Merck's (NYSE: MRK In a second study, Prevnar 13 appears to work well as a booster shot, meaning it can be used earlier than...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Pfizer's Multibillion-Dollar Blockbuster Set to Grow
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account